ALPN Annual Operating Profit
-$44.25 M
+$13.90 M+23.90%
31 December 2023
Summary:
As of February 5, 2025, ALPN annual operaing income is -$44.25 million, with the most recent change of +$13.90 million (+23.90%) on December 31, 2023. During the last 3 years, it has fallen by -$15.50 million (-53.92%).ALPN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALPN Quarterly Operating Profit
-$22.70 M
-$24.24 M-1567.10%
01 March 2024
Summary:
As of February 5, 2025, ALPN quarterly operating income is -$22.70 million, with the most recent change of -$24.24 million (-1567.10%) on March 1, 2024. Over the past year, it has dropped by -$8.15 million (-55.99%).ALPN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALPN TTM Operating Profit
-$51.35 M
-$7.10 M-16.05%
01 March 2024
Summary:
As of February 5, 2025, ALPN TTM operating income is -$51.35 million, with the most recent change of -$7.10 million (-16.05%) on March 1, 2024. Over the past year, it has increased by +$14.81 million (+22.39%).ALPN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALPN Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.9% | -56.0% | +22.4% |
| 3 y3 years | -53.9% | -56.0% | +22.4% |
| 5 y5 years | -20.8% | -56.0% | +22.4% |
ALPN Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +390.1% | -1567.1% | +1069.8% |
Alpine Immune Sciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$22.70 M(-1567.1%) | -$51.35 M(+16.1%) |
| Dec 2023 | -$44.25 M(-23.9%) | $1.55 M(-110.6%) | -$44.25 M(-33.1%) |
| Sept 2023 | - | -$14.55 M(-7.1%) | -$66.17 M(+1.1%) |
| June 2023 | - | -$15.65 M(+0.4%) | -$65.45 M(-1.3%) |
| Mar 2023 | - | -$15.59 M(-23.5%) | -$66.28 M(+14.0%) |
| Dec 2022 | -$58.15 M(+16.6%) | -$20.37 M(+47.3%) | -$58.15 M(+9.4%) |
| Sept 2022 | - | -$13.83 M(-16.1%) | -$53.15 M(+1.1%) |
| June 2022 | - | -$16.49 M(+121.1%) | -$52.59 M(+12.3%) |
| Mar 2022 | - | -$7.46 M(-51.5%) | -$46.83 M(-6.1%) |
| Dec 2021 | -$49.86 M(+73.4%) | -$15.38 M(+15.9%) | -$49.86 M(+21.8%) |
| Sept 2021 | - | -$13.26 M(+23.6%) | -$40.94 M(+18.2%) |
| June 2021 | - | -$10.73 M(+2.3%) | -$34.65 M(+2.9%) |
| Mar 2021 | - | -$10.49 M(+62.3%) | -$33.67 M(+17.1%) |
| Dec 2020 | -$28.75 M(-34.0%) | -$6.46 M(-7.3%) | -$28.75 M(-1.9%) |
| Sept 2020 | - | -$6.97 M(-28.5%) | -$29.30 M(-13.9%) |
| June 2020 | - | -$9.75 M(+75.2%) | -$34.04 M(-6.6%) |
| Mar 2020 | - | -$5.57 M(-20.7%) | -$36.44 M(-16.4%) |
| Dec 2019 | -$43.57 M(+19.0%) | -$7.02 M(-40.1%) | -$43.57 M(-9.2%) |
| Sept 2019 | - | -$11.71 M(-3.6%) | -$48.00 M(-1.4%) |
| June 2019 | - | -$12.15 M(-4.3%) | -$48.68 M(+11.3%) |
| Mar 2019 | - | -$12.70 M(+10.9%) | -$43.74 M(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$36.63 M(+144.6%) | -$11.45 M(-7.6%) | -$36.63 M(+22.2%) |
| Sept 2018 | - | -$12.39 M(+71.8%) | -$29.97 M(+35.4%) |
| June 2018 | - | -$7.21 M(+29.1%) | -$22.14 M(+23.8%) |
| Mar 2018 | - | -$5.58 M(+16.6%) | -$17.88 M(+0.3%) |
| Dec 2017 | -$14.97 M(-53.1%) | -$4.79 M(+5.2%) | -$17.83 M(-14.5%) |
| Sept 2017 | - | -$4.55 M(+54.3%) | -$20.87 M(-12.5%) |
| June 2017 | - | -$2.95 M(-46.7%) | -$23.86 M(-19.1%) |
| Mar 2017 | - | -$5.54 M(-29.2%) | -$29.51 M(-7.5%) |
| Dec 2016 | -$31.90 M(+39.3%) | -$7.82 M(+3.7%) | -$31.90 M(+3.9%) |
| Sept 2016 | - | -$7.55 M(-12.2%) | -$30.71 M(+4.9%) |
| June 2016 | - | -$8.60 M(+8.3%) | -$29.26 M(+10.3%) |
| Mar 2016 | - | -$7.93 M(+19.7%) | -$26.52 M(+15.8%) |
| Dec 2015 | -$22.90 M(+58.1%) | -$6.63 M(+8.7%) | -$22.90 M(+15.9%) |
| Sept 2015 | - | -$6.10 M(+4.3%) | -$19.75 M(+21.1%) |
| June 2015 | - | -$5.85 M(+35.6%) | -$16.31 M(+13.1%) |
| Mar 2015 | - | -$4.32 M(+23.8%) | -$14.41 M(-0.5%) |
| Dec 2014 | -$14.49 M(-5.2%) | -$3.49 M(+31.3%) | -$14.49 M(+31.7%) |
| Sept 2014 | - | -$2.65 M(-32.9%) | -$11.00 M(+31.8%) |
| June 2014 | - | -$3.96 M(-9.9%) | -$8.35 M(+90.1%) |
| Mar 2014 | - | -$4.39 M | -$4.39 M |
| Dec 2013 | -$15.28 M(+69.2%) | - | - |
| Dec 2012 | -$9.03 M | - | - |
FAQ
- What is Alpine Immune Sciences annual operaing income?
- What is the all time high annual operating profit for Alpine Immune Sciences?
- What is Alpine Immune Sciences annual operating profit year-on-year change?
- What is Alpine Immune Sciences quarterly operating income?
- What is the all time high quarterly operating profit for Alpine Immune Sciences?
- What is Alpine Immune Sciences quarterly operating profit year-on-year change?
- What is Alpine Immune Sciences TTM operating income?
- What is the all time high TTM operating profit for Alpine Immune Sciences?
- What is Alpine Immune Sciences TTM operating profit year-on-year change?
What is Alpine Immune Sciences annual operaing income?
The current annual operating profit of ALPN is -$44.25 M
What is the all time high annual operating profit for Alpine Immune Sciences?
Alpine Immune Sciences all-time high annual operaing income is -$9.03 M
What is Alpine Immune Sciences annual operating profit year-on-year change?
Over the past year, ALPN annual operaing income has changed by +$13.90 M (+23.90%)
What is Alpine Immune Sciences quarterly operating income?
The current quarterly operating profit of ALPN is -$22.70 M
What is the all time high quarterly operating profit for Alpine Immune Sciences?
Alpine Immune Sciences all-time high quarterly operating income is $1.55 M
What is Alpine Immune Sciences quarterly operating profit year-on-year change?
Over the past year, ALPN quarterly operating income has changed by -$8.15 M (-55.99%)
What is Alpine Immune Sciences TTM operating income?
The current TTM operating profit of ALPN is -$51.35 M
What is the all time high TTM operating profit for Alpine Immune Sciences?
Alpine Immune Sciences all-time high TTM operating income is -$4.39 M
What is Alpine Immune Sciences TTM operating profit year-on-year change?
Over the past year, ALPN TTM operating income has changed by +$14.81 M (+22.39%)